AI-assisted, human-published
01/08/2025 /Funding Events
Alesta Therapeutics Secures €65M Series A Financing for Rare Disease Therapies
Netherlands-based biotech company, Alesta Therapeutics, closes an oversubscribed financing round led by Frazier Life Sciences and Droia Ventures for the development of small molecule therapies for rare diseases.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com